Switzerland · 
Who invested in Bright Peak Therapeutics?
Bright Peak Therapeutics's investors include Venrock, RA Capital Management, Fidelity, BlackRock and Versant Ventures.
Switzerland · Series C startup
Who invested in Bright Peak Therapeutics
Funding summaryUpdated 26 Oct 2026
$90Mraised across 1 round since 2024, from 1 source
- Latest round
- Series C, $90MJun 2024
- Investors
- 5
The rounds
- Jun 2024Series C$90M
Source recordedSEC filing: $90M sold, first sale May 2024
Founders and team
From Bright Peak Therapeutics's own website: 5 on the team.
- Fredrik WiklundChief Executive Officer
- Robert Tam PhDVice President of Program Management
- Vijaya Pattabiraman PhDChief Technology Officer
- Izabela Zöger BScBoard of Directors
- John SchmidIndependent Director
Everyone who backed them
FidelityVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Bright Peak Therapeutics
How much has Bright Peak Therapeutics raised?
Bright Peak Therapeutics has raised $90M across 1 round since 2024.
When did Bright Peak Therapeutics last raise?
Bright Peak Therapeutics's most recent round was a Series C of $90M in Jun 2024.
What was Bright Peak Therapeutics's biggest round?
Its most recent round, $90M in Jun 2024, is also its largest on record.
Who backed Bright Peak Therapeutics first?
Bright Peak Therapeutics's first round on record, in Jun 2024, was backed by Venrock, RA Capital Management and Fidelity and 2 others.
What stage is Bright Peak Therapeutics at?
Bright Peak Therapeutics's latest named round is a Series C, in Jun 2024.
Where is Bright Peak Therapeutics based?
Bright Peak Therapeutics is based in Switzerland.
Companies like Bright Peak Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.